Impact Factor
4.14
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
7.74
482 total citations
h5-index
33
h5 depth signal
Cited share
96.9%
63 of 65
Total citations
482
Citation footprint
Metric signal
7.87
External metric anchor
Self-citation
2.3%
11 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
75
Canada
60
Italy
42
China
34
France
24
Citing Fields of Research
Clinical Laboratory Science
123
Hematology
30
Immunology
29
Cardiology
22
Mass Spectrometry
20
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
742
Articles tracked across the journal lifetime
Indexed publication set
65
63 cited publications
Last 12 months
35
3.2 publications/month
Open access share
20.0%
7 OA publications in the last year
Leading citing country
United States
75 citing publications
Leading citing field
Clinical Laboratory Science
123 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v12n3, 1980-
v12n3, 1980-
Active Coverage
Research Focus & Classification
Indexed Subjects
Clinical Laboratory Science
Issuing & Sponsoring Bodies
Contributor
Chemical Rubber Company
Broad Categories
Clinical Laboratory Techniques
Clinical Laboratory Science
Cardiology
Lung Cancer
Genetics & Genomics
Urology
Endocrinology & Metabolism
Neuromuscular Disorders
MeSH Descriptors
Clinical Laboratory Techniques
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/10408363.2026.2743757
Open DOI
Rethinking hyperhomocysteinemia: from causal risk factor to biomarker of glutathione deficiency in chronic diseases
02
DOI 10.1080/10408363.2026.2735636
Open DOI
The association between viral infections and aplastic anemia: a comprehensive scoping review
03
DOI 10.1080/10408363.2026.2742201
Open DOI
Proteasuria: extending an existing term into a framework for concentration-based and catalytic protease diagnostics in urine, with emphasis on activity-based methods
Proteases are central to cancer pathobiology and attractive targets for noninvasive diagnosis. Diagnostic use of urinary proteases has developed along two methodologically distinct streams: measurement of protein abundance by immunoassay...
04
DOI 10.1080/10408363.2026.2742200
Open DOI
Non-coding RNAs as potential clinical biomarkers of heart failure: analytical validation, laboratory methodology, and clinical implementation pathways
Heart failure (HF) is a heterogeneous clinical syndrome that has pathophysiologic manifestations of hemodynamic abnormalities, downstream neurohumoral activation and inflammation, myocardial fibrosis, metabolic dysfunction, and cardiomyo...
05
06
DOI 10.1080/10408363.2026.2722682
Open DOI
Continuous glucose monitoring devices in hospitalized pediatric patients
Diabetes in the pediatric population is a global health challenge, with a rising incidence of both type 1 and type 2 diabetes in children and adolescents. From 1990 to 2019, the prevalence of child...
07
DOI 10.1080/10408363.2026.2718329
Open DOI
Critical result thresholds and notification practices in clinical laboratories
Laboratory testing accounts for less than 5% of the health care budget in the United States and Europe, but laboratory results impact up to 50% of clinical decisions depending on the medical specia...
08
DOI 10.1080/10408363.2026.2716664
Open DOI
Diagnosis and monitoring of metabolic dysfunction-associated steatohepatitis disease: a critical review
09
DOI 10.1080/10408363.2026.2712373
Open DOI
Laboratory information system implementation and electronic health record integration: challenges, opportunities, and practical strategies
The laboratory information system (LIS) is a central and indispensable component of the contemporary clinical laboratory, supporting day-to-day operations and playing a critical role in sustaining ...
10
DOI 10.1080/10408363.2026.2713153
Open DOI
The interplay between chronic inflammation and tumorigenesis: unraveling the inflammation-driven axis
1. The development of tumors is a multifactorial process involving genetic predisposition, environmental exposure and the dynamic interplay of immune dysregulation over time. Mounting evidence sugg...
Bibliographical & Catalog Notes
Print issues ceased with v. 50 (2013).
Also issued online.
Vol. 14, no. 1 (1981)19920818 Notice not published Printed on acid-free paper